Global Whole Genome Amplification Market, By Product (Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA and Chip DNA Kit, Others), Application (Drug Discovery and Development, Disease Diagnosis, Agriculture and Veterinary, Research, Forensics, Others), End User (Pharma and Biotech Companies, Hospitals and Clinics, Contract Research, Organizations, Research and Academic Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Whole Genome Amplification Market
The whole genome amplification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.90% in the forecast period of 2021 to 2028 and is expected to reach USD 4,492.52 million by 2028. The high application of the method in the various fields of the biological fields is escalating the growth of the whole genome amplification market.
Whole genome amplification (WGA) refers to a method which assists in amplifying the entire DNA with the help of small sample of a genomic DNA. WGA is gaining popularity as it helps in enhancing the number of the limited samples with respect to DNA. This method is utilized for studying any gene of any organism by preserved limited sample. This application is extensively used in diverse range of applications in research associated with the genetic diseases and forensics among others. To whole genome amplification method utilizes the polymerase chain reaction principals to enzymatically copy the DNA from a genome sample.
The increasing adoption of whole genome amplification (WGA) for the examination of sequence information with the optimized next generation sequencing technologies with the help of a single cell and the use of this method as a powerful tool which assists in understanding the ins and outs of genetics by putting the entire genome structure to a cellular level act as the major factors driving the whole genome amplification market. The use of this method for providing a high-resolution view of the genomic sample and its application diverse biological fields such as immunology, neurobiology, microbiology and tissue mosaicism and cancer research also influence the whole genome amplification market. Additionally, the single cell WGA plays a crucial role in conveying new applications and the dependence of screening for various neurological and developmental genetic disorders on single-cell whole genome amplification positively affect the whole genome amplification market. Furthermore, the development of advanced devices and kits and introduction of novel techniques extend profitable opportunity to the whole genome amplification market players in the forecast period of 2021 to 2028.
On the other hand, the rise in concerns regarding the biased and underrepresented loci PCR WGA causing lack of trust on the process is expected to obstruct the whole genome amplification market growth. The decline in the revenue for the method is projected to challenge the whole genome amplification market in the forecast period of 2021-2028.
This whole genome amplification market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on whole genome amplification market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Whole Genome Amplification Market Scope and Market Size
The whole genome amplification market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the whole genome amplification market is segmented into single cell WGA kit, complete WGA kit, WGA reamplification kit, WGA and chip DNA kit and others.
- On the basis of application, the whole genome amplification market is segmented into drug discovery and development, disease diagnosis, agriculture and veterinary, research, forensics and others.
- On the basis of end user, the whole genome amplification market is segmented into pharma and biotech companies, hospitals and clinics, contract research, organizations, research and academic institutes and others.
Global Whole Genome Amplification Market Country Level Analysis
The whole genome amplification market is analyzed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the global whole genome amplification market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the whole genome amplification market because of the increase in the awareness about genome amplification in the region. Asia-Pacific is expected to witness the highest CAGR in the forecast period of 2021-2028 because of its increasing uses in research for genetic disorders and forensics and developments related to technology and new product’s introduction by local market players in the region.
The country section of the whole genome amplification market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The whole genome amplification market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for whole genome amplification market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on whole genome amplification market. The data is available for historic period 2011-2019.
Competitive Landscape and Whole Genome Amplification Market Share Analysis
The whole genome amplification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to whole genome amplification market.
The major players covered in the whole genome amplification market report are Merck KGaA, QIAGEN, GENERAL ELECTRIC COMPANY, LGC Limited, Illumina, Inc., Thermo Fisher Scientific, Inc., Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., BGI, Danaher, Eppendorf AG, Active Motif, Takara Bio Inc., MJH Life Sciences and BioPharm International among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-